COVID-19 and the Future of Our Health Research and Innovation System
Life Sciences Ontario, in collaboration with Shift Health, is convening an online session, “COVID-19 and the Future of Our Health Research and Innovation System” on May 28 from 3:00 to 4:30 pm EDT. Speakers include: Dr. Jim Tartaglia, Vice-President R&D, Global Head of Projects, Sanofi Pasteur; Connie Côté, CEO, Health Charites Coalition of Canada; CIHR’s Institute of Infection and Immunity; Bogi Eliasen, Director of Health, Copenhagen Institute for Futures Studies; and Dr. Ryan Wiley, President, Shift Health. More details are available here. To read “COVID-19 and the Future of Health Research and Innovation”, a recent report published by Shift Health, please click here.

Dr. Fei-Fei Liu was named Scientific Director of CIHR's Institute of Cancer Research (ICR) effective September 1, 2022. Dr. Liu has worked for more than three decades as a Clinician Scientist at the Princess Margaret Cancer Centre, where she is also the Chief of the Radiation...
In rapid response to the unfolding health human resources (HHR) crisis, CIHR and Health Canada will support up to 17 policy research projects relevant to any of four HHR themes aiming to advance evidence-informed policy options, solutions and strategies to address the current h...